Alvarado, Arlyn A.
HRN: 08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/08/2022
04/15/2022
IV
115mg
Q6h
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes